by Ket Patel | Aug 25, 2012 | All Articles For Neurology, Alzheimer's Disease
Eli Lilly’s experimental Alzheimer’s drug solanezumab failed to have statistically significant benefits in the primary end points of two phase III trials but showed possible early cognitive benefits in secondary analyses, the company announced Aug. 24. The...
by Ket Patel | Aug 24, 2012 | Psychiatry
Dr. Leslie Gee walked into a local smoke shop near Stanford in May 2012 and bought a packet of synthetic cannabinoids 7 months after California banned similar versions. That’s just one of many designer drugs that adolescents are using and abusing, with effects that...
by Ket Patel | Aug 22, 2012 | All Articles For Psychiatry, Sleep Disorders
BOSTON – Treatment with continuous positive airway pressure does double duty in patients with obstructive sleep apnea by improving their mood while promoting restful sleep, Dr. Charles Bae reported at the annual meeting of the Associated Professional Sleep Societies....
by Ket Patel | Aug 22, 2012 | All Articles For Neurology, Epilepsy
The total defined daily dose of antiepileptic drugs was the best predictor of medication side effects in a clinical prediction rule developed from a single-center, cross-sectional study of 801 patients with epilepsy. The finding stands in contrast to a previous study...
by Ket Patel | Aug 22, 2012 | All Articles For Psychiatry, Schizophrenia
Patients with schizophrenia who are heavy cigarette smokers are more likely to use substances such as alcohol than are those with the disease who are non–heavy smokers. Heavy smokers also are more likely to have elevated cholesterol, a retrospective analysis of 745...
